The blood volumes and concentrations of thromboxane B , (TxB,), platelet factor 4 (PF4), and fibrinopeptide A (FPA)
proximal and distal ends of transected vessel^.^^^^^^^-" Fibrin is rarely observed within the plug, but fibers with the characteristics of fibrin are seen at the periphery of the plug and, more prominently, along the edges of the wound, which may also contain foci of adherent platelets. The final arrest of bleeding is associated with further growth of the platelet plug and a more extensive network of fibrin, which caps the plug and fills the wound.6,8-'0 In patients (or animals) with thromb~cytopenia'*~' or von Willebrand's disease (vWD),~,','~ in whom the bleeding time is greatly increased, platelet plugs were greatly reduced at the ends of transected vessels. Thus, these various studies have shown the importance of platelets in the primary arrest of bleeding and provided direct evidence that von Willebrand factor (vWF), which binds to both platelet glycoprotein (GP) Ib and GP IIb-IIIaI4 and promotes platelet thrombus formation on subendotheli~m,'~ plays an important role in platelet-plug formation. Less is known about the importance of fibrin formation in the primary arrest of bleeding. In patients with defects in the classical "extrinsic" coagulation mechanism, such as those with deficiencies of factor V or factor X,I6 and afibrinogenemia," the bleeding time may be prolonged, suggesting that fibrin deposition at the periphery ofthe platelet plug, and within the wound, may be important.
Although the above studies have provided important information about the role of platelets, and possibly fibrin, in (FPA) values were increased in early bleeding samples (initial slope). In vitro studies of TxB, production, together with previous flow studies of fibrin formation, also suggest enhanced activation and coagulant properties of thrombasthenic platelets. In other patients, reduced values of all substances at later times may reflect impaired platelet-fibrin plug formation in the high-shear regions at the ends of transected blood vessels. However, the initial slopes of the fitted curves for both TxB, and PF4 were normal in vWD, suggesting that the early appearance of these substances may typically be from platelets that are adherent to collagen within the lower shear environment of the wound surface. The finding that FPA values were not decreased initially in any patient group, including ITP, but were decreased at later times (except for TSA), suggests that early fibrin formation occurs independently of platelets in the low-shear environment of the wound surface, whereas at later times fibrin is formed in a platelet-dependent manner in the high-shear regions at the ends of transected vessels. 0 1993 by The American Society of Hematology.
the arrest of bleeding, they are limited by the number of biopsy specimens and tissue sections that are available for study. A technique has recently been developed for collecting, at regular intervals, the blood emerging from skin bleeding time wounds and determining the concentrations of fibrinopeptide A (FPA), platelet factor 4 (PF4), P-thromboglobulin, or thromboxane B, (TxB,),'~,'*-~' which presumably are a measure of overall platelet activation and fibrin formation throughout the wound. Using this technique in patients with coagulation defects, we have shown that the production of FFA in the wounds is through a pathway dependent on tissue factor-factor VI1 activation of factor X.I6 In this report we present the result of studies in which platelet (TxB, and PF4) and coagulation (FPA) activation products, as well as the rate of bleeding, were measured in patients with vWD or with various well-characterized platelet disorders to examine further the mechanisms that may be involved during the primary arrest of bleeding. The platelet disorders studied included idiopathic thrombocytopenic purpura (ITP), Glanzmann's thrombasthenia (TSA) (GPIIb-
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IIIa deficiency), the Bernard-Soulier Syndrome (BSS; GPIb deficiency), and storage pool deficiency (SPD) associated with either specific deficiencies in dense granule substances (CSPD) or deficiencies in both dense granule and a-granule substances (a&SPD).22,23
MATERIALS AND METHODS

Bleeding Time and Collection oflncision Blood For SequentialMeasurement of Blood Loss and Radioimmunoassay
The procedures for measuring the volume or TxB,, PF4, and FPA concentrations sequentially in samples of bleeding-time blood were those described previously.'6 Briefly, after compressing the upper arm with a sphygmomanometer cuff to a pressure of 40 mm Hg, two simultaneous longitudinal incisions were made on the volar surface of the forearm using a Simplate I1 bleeding-time device (Organon-Teknica Corp, Durham, NC). At 30-second intervals until bleeding stopped (normal subjects) or 15 minutes (patients), blood from each of the two wounds was collected into heparinized microhematocrit capillary tubes of known diameter (Fisher Scientific CO, Pittsburgh PA) and, after measuring the height ofthe blood column, the blood was expressed into microcentrifuge tubes containing buffered saline plus either indomethacin and EDTA (for measurement of TxB, in blood from the proximal wound), or heparin, trasylol (aprotonin), EDTA, indomethacin, adenosine, and theophylline (for measurement of PF4 and FPA levels in blood from the distal wound). The diluted blood samples were then centrifuged, and aliquots of the supernatants were processed for FPA radioimmunoassay before freezing at -80°C. 16 All aliquots were stored at -80°C before determination of PF4, TxB,, or FPA by radioimmunoassay, as described in detail previously. '6 All studies were performed under a protocol approved by the Institutional Review Board of the St Luke's-Roosevelt Institute for Health Sciences.
TxB, Formation in Gel-Filtered Platelets (GFP)
Platelet-rich plasma was prepared from acid-citrate-dextrose (ACD)-anticoagulated blood by centrifugation for 3 minutes at 1,OOOg and gel-filtered into Ca-free Tyrode's buffer containing 5 nimol/L HEPES, 0.1% glucose, and 0.2% bovine albumin as described previ~usly?~ Aliquots (0.9 mL) of GFP adjusted to a platelet count of 200,OOO/pL were incubated at 37°C with stimng for 1 minute with the addition of elution buffer or with stimng for 2 minutes with the addition of 88 pg/mL U-CP8, a monoclonal antibody (MoAb) specific for the GPIIb-IIIa c o m p l e~~~ kindly provided by Dr Zaverio Ruggeri (The Scripps Research Institute, La Jolla, CA). Thrombin was then added in final concentrations varying from 0.05 to 5 U/mL for a period of 5 minutes, after which 100 pL of the platelet suspension was added to 500 pL of ice-cold phosphate-buffered saline (PBS)-5 mmol/L EDTA-12 pmol/L indomethacin and processed for measurement of TxB, by radioimmunoassay as described previously."' Serum TxB, and PF4 Two-milliliter aliquots of nonanticoagulated venous blood to which bovine thrombin (Parke-Davis, Detroit, MI) was added to a final concentration of 2 U/mL were incubated at 37°C for 30 minutes. Serum was separated by centrifugation at 17,500g for I O minutes at 4"C, and frozen at -80°C before assay of TxB, and PF4.
Subjects
Control subjects (n = 15) were normal hospital personnel, 25 to 50 years of age, who denied recent ingestion of Normal subjects. drugs known to affect platelet function or hemostasis. Studies on the patients reported herein were performed both contemporaneously with those in the previously reported studieP and subsequent to those studies. Hence, the control subjects comprise both those previously reported plus additional normal subjects studied during the latter part of the present studies. The average value for the platelet count was 3 19,000 * l5,000/pL and for serum TxB, was 1,25 1 f 99 pmol/mL. v WD. Three previously de~cribed~~.~* patients (C.M., D.R., and W.D.) with severe type I11 vWD have undetectable levels of vWF antigen (vWFAg) by either Laurel1 electroimmunoassay (<0.06 U/ mL) or immunoradiometric assay (10.003 U/mL),29 and undetectable ristocetin cofactor activity (<0.03 U/mL).29 Factor VI11 levels in C.M. and D.R., assayed on multiple occasions, ranged from less than 0.01 to 0.05 U/mL, and in patient W.D. were 0.05 to .08 U/mL, assayed as previously de~cribed.'~ The average value for the platelet count was 296,000 + 6,000/pL, and for serum TxB, was 1,4 19 + 290 pmol/mL. In these patients, platelet adhesion to subendothelium is decreased in citrated blood at a shear rate of 800 s-' and, more strikingly, at shear rates of 1,300 s-' and above." In nonanticoagulated blood, adhesion is decreased at shear rates of 2,600 s? and above, but not at 1,300 sK' or be lo^.^^,^ Platelet thrombus formation is decreased, even under conditions in which adhesion is normal."
TSA. Four previously describedz7 patients (M.C., C.G., L.W., and M.Mo) with Glanzmann's TSA were studied. All four patients have markedly reduced or absent amounts of the GPIIb-IIIa comp l e~*~ and their platelets do not aggregate with 50 pmol/L adenosine diphosphate (ADP) or epinephrine, nor with 20 pg/mL collagen. Platelet adenine nucleotide and serotonin values are normal. The average value for the platelet count was 212,000 f 21,00O/pL and for serum TxB, was I , 176 f 260 pmol/mL. Platelet thrombus formation on subendothelium is absent at all shear Platelet adhesion to subendothelium in citrated blood is decreased at shear rates of 800 and 2,600 s-',*~ caused by a defect in platelet ~preading.'~ In nonanticoagulated blood, adhesion is normal at these shear rates, but platelet spreading is defe~tive.'~ Fibrin formation and FPA production are increased."
BSS. Two previously r e~o r t e d '~.~~ patients (A.J. and T.H.) whose findings are typical of the BSS were studied. Previous studies on these patients have shown absent platelet aggregation with ristoeti in,^^ decreased platelet GPIb content,34 impaired platelet adhesion to subendothelium in citrated blood at shear rates of 800 s-' and ab0ve,2'.~.~' and decreased adhesion in nonanticoagulated blood at shear rates of 650 s-' and above.30s31 Platelet-thrombus formation is also markedly defective." The average value for the platelet count was 84,OOO/pL and for serum TxB, was 462 pmol/ mL.
SPD. Fourpatients(L.V., W.A.,N.R.,andJ.V.)withthealbin-
ism variant of 6-SPD (Hermansky-Pudlak syndrome) were studied. All four patients were of Puerto Rican ancestry and had the typical clinical features of this syndrome, including a history of excessive bruising and bleeding at surgical procedures, oculocutaneous albinism, and nystagmus. Platelets in 6-SPD are specifically deficient in dense granule substance^.*^.^^ The average values (+SE) for these substances, assayed as described previo~sly,~~ in the platelets of these four patients (versus normal control subjects) were: adenosine triphosphate (ATP) = 3. In nonanticoagulated blood of both albino 6-SPD patients and a6-SPD patients, platelet thrombi on subendothelium are decreased at shear rates of 650 s-' and above. 27 Thrombocytopenia. Four adult patients with the characteristic findings of chronic ITP were studied. The average value for the platelet count was 20,000 f 4,00O/pL, and for serum TxB, was 3 17 k 175 pmol/mL. No evidence for an underlying disease that might have accounted for the thrombocytopenia was found in any ofthese patients.
Other Studies
The hematocrit values in the various patient and normal groups varied from 38 f 3 (ITP) to 43 2 4 (vWD). Serum PF4, compared with normal values (8,804 f 1,008 ng/mL), was significantly decreased in a6-SPD (1,700 f 345) and ITP (1,093 & 268) and was normal in the other patient groups. Average plasma fibrinogen values varied from 207 to 28 1 mg per 100 mL in the various groups.
Curve Fitting
The data obtained from control subjects and patient groups were fitted to second-order (TxB,, PF4, and FPA) or third-order (volumes) polynomials using a Sigmaplot computer program, equation coefficients, their SD, and the 95% or 99% confidence limits of the curve. From these values the initial slope and the parameter values at any 30-second interval could be calculated. The initial slope for each parameter was taken as the first-order coefficient derived from curve fitting of the data obtained during the first 6 minutes of bleeding only. Although these curves provided excellent fits for the experimental data and enabled calculation of several parameters of interest, they are entirely empirical and do not neces sarily imply any particular model of hemostasis. In particular, the calculation of the initial slope is intended to reflect the rate of bleeding during the early stages of hemostasis and not the instantaneous rate of bleeding at time zero after transection of the vessel.
Numerical Analysis
Average values for the parameters were determined by a method in which the area under a curve is evaluated numerically by means of an integration formula obtained by interpolating parabolas through a number of pivotal points of the integrand, using the area under the parabolas as an approximation to the area under the integrand (Simpson's rule),36 and dividing by the time interval over which the area was determined.
Statistical Analysis
The significance of the difference between two means was evaluated by Student's t-test. For multiple data points (formation of TxB, by incremental concentrations of thrombin), differences between controls and patient groups were compared by analysis of variance (ANOV).37 Figure 1 shows, for each subject group, the average bleeding-time blood volumes versus time. In normal subjects, blood volume increased to a maximum value at 2 minutes 11.1; P = NS) or vWD disease (42.7 & 10; P = NS). Figure 2 depicts the average group values for TxB, in the bleeding-time samples, as well as the fitted second-order curves. Except that the experimental values are somewhat higher than those in the previous report,16 the fitted secondorder curve for the expanded group of normal subjects shows, as shown previously,16 the relatively slow increase in TxB, during the early time points and the more rapid increase that coincides with slowing, and then cessation, of bleeding.
RESULTS
Bleeding-Time Blood Volumes
TxBZ
TxB, in bleeding-time blood was markedly decreased in ITP patients, indicating its platelet origin. TxB, was also markedly decreased in patients with as-SPD, in whom decreased platelet malondialdehyde production from arachi-
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donate was reported previou~ly,~~ and was undetectable in any of the samples obtained during the first 5 minutes in the two patients with BSS. In contrast, the initial slopes of the fitted curves'in patients with vWD and 6-SPD were not decreased, compared with controls (2.84 ? 0.14 and 3.07 f 0.14 v 1.96 f 0.20), although decreased values were obtained at 5 minutes (7.0 ? 1.3 and 10.9 ? 1.5 v 40.1 ? 3.0 pmol/mL). In both disorders, the average TxB, concentration during the first 5 minutes was also less than that in controls (6.2 k 1.8 and 5.7 k 1.6 v 14.3 k 4.6 pmol/mL), as reported in other studies,39 but the differences were not significant.
In contrast to the findings in every other platelet disorder, TxB, levels were increased (P Enhanced TxB, production in thrombasthenics was also observed in vitro (Fig 3A) . TxB, production induced by a range of thrombin concentrations was significantly greater (P < .05, ANOV) in thrombasthenic GFP than in normal GFP. This increased capacity for TxB, formation is also evident in these patients' serum TxB, value when this value is corrected for their lower platelet count (see Materials and Methods). However, no increased TxB, production was observed in normal platelets in which the GPIIb-IIIa complex had been blocked by incubation in vitro with the complexspecific MoAb U-CP8 (Fig 3B) . 
THROMBIN CONCENTRATION (UlrrJ)
were, in general, similar to those for TxB,. Decreased PF4 generation was observed in ITP, BSS, and in patients with cu6-SPD, whose platelets contain reduced amounts of PF4.
As with TxB,, the initial slopes of the fitted curves, compared with controls (201 f 8), were not decreased in vWD (261 k 10) and 6-SPD (285 f 9), whereas the 219 ng/mL in controls; P < .05).
DISCUSSION
The patterns of TxB,, PF4, and FPA concentrations observed in the bleeding-time blood of patients with well-defined disorders of platelet function, together with the abnor- malities of platelet adhesion, thrombus formation, and fibrin deposition previously described in these patients, may provide some insights into mechanisms of platelet activation and of thrombin generation that occur normally after transection of blood vessels. In addition, differences in the initial blood flow that were observed among these patients may reflect specific properties of platelets that modulate vascular tone.
Blood Flow
Blood volumes in normal subjects increased during the early stages of bleeding, reaching a maximum at approximately 2 minutes (Fig 1) . Previous studies have shown that vessels contract rapidly after their transection, ',2,4~12 possibly caused by neuronal2 or direct smooth m~s c l e~.~ stimulation, reduced intraluminal pressure,' or endothelin derived from injured endothelial cells.40 After contraction, the vessels rapidly dilate,'.2 which could account for the increased blood volumes in sequential samples obtained during the first 2 minutes after the incision.
The mechanisms involved in vascular dilatation are not well understood, but the increased early bleeding observed in ITP and some of the other patient groups, as reflected by the calculated initial slopes of the fitted curves, suggests that substances released from platelets, which are known to influence vascular tone,'.4 may modulate this response. The increased early bleeding in 6-SPD suggests that platelet dense granule substances, such as ATP and serotonin in particular, may play an important role in regulating vessel diameter after transection, as they have been shown previously to influence the time to the arrest of bleeding.4 ' The role of ATP and serotonin in influencing vascular tone is complex.4245 In large arteries, these substances directly cause vessel contraction if endothelial cells are injured or Ho wever, in the presence of endothelium, they induce these cells to synthesize endothelium-derived relaxing factor (EDRF)?' which has been identified as either nitric oxide (NO)49 or a substance that yields NO under appropriate condition^,^' and which causes large vessel to dilate. The effects of ATP and/or serotonin on smaller vessels, in the presence or absence of endothelial cell injury, is less clear. However, the increased early blood flow observed in patients with 6-SPD suggests that the absence of these substances from the milieu of a transected vessel in a bleeding-time wound may result in a more rapid dilatation of the vessel.
The initial bleeding was also increased in patients with BSS, but not in those with vWD or TSA. These findings are consistent with the hypothesis suggested below that platelet adhesion (and hence the subsequent dense-granule secretion) may be normal initially on the various wound surfaces in TSA and vWD, but is more severely impaired in BSS.
Platelet Activation
For normal subjects, Figs 2 and 4 show the relatively slow increase in TxB, and PF4 during the early bleeding-time samples and the more rapid increases that coincide with slowing and then cessation of bleeding. The almost total absence of TxB, and PF4 in all bleeding-time samples (early and late) from patients with ITP is consistent with the platelet origin of these substances. Plausible sources for these substances are platelets that are adherent to ~o l l a g e n ,~J~ and/or those that are recruited to form a hemostatic plug at the ends of transected ve~sels~,~,~,*-l' or along the edges of the
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V-shaped wound.'-l' In addition, nonadherent platelets in the flowing blood could also be activated by thrombin. However, previous findings that early formation of TxB, is normal in patients with severe deficiencies of factor V or X, in whom FPA levels were undetectable,I6 suggest that thrombin may not be absolutely required for early platelet activation in bleeding-time wounds,
The normal values for TxB, and PF4 in early bleedingtime samples of patients with vWD, as reflected by the initial slopes of the fitted curves, is somewhat surprising in view of the defect in platelet adhesion that has been shown in this di~order.'~,~' However, this defect is highly shear-rate dependent3' and was observed in nonanticoagulated blood only at shear rates greater than 1,300 s-',~' a value that might be anticipated at the proximal ends of the transected arteriole^.^' Thus, the normal early values for TxB, and PF4 in vWD suggest that these substances are derived from platelets that have adhered initially to collagen (or other substrates) within the lower shear environmentL6 of the wound surface, at the ends of transected venules, or at the ends of the transected distal arterioles, where flow is reversed." This would also be consistent with the normal initial blood flow noted above in vWD.
The most pronounced reductions in TxB, and PF4 were observed in the two patients with BSS. Because BSS platelets can produce TxB, and secrete PF4 (See Materials and Methods), their total absence (TxB, , Fig 2) or marked reduction (PF4, Fig 4) in bleeding-time wounds could be caused by an impairment of adhesion that is more eve re,^' and that is observed at lower shear rates,53 than that in platelets from patients with vWD. Whether such an impairment may be related solely to the GPIb defect, or to additional defects in BSS platelets, is not clear at present.53
In contrast to the variably decreased values for TxB, and PF4 in early bleeding-time samples, reduced amounts of these substances were found in later bleeding-time blood from all of the patient groups except thrombasthenics (see below). In normal subjects, the formation of a hemostatically effective plug consisting of closely packed platelets during the later phase of bleeding (2 to 5 minutes)','' probably accounts for the rapid increases in the concentrations of TxB, and PF4 (Figs 2 and 4) , as well as the sharp decrease in blood volume. One possible explanation for the reduced amounts of TxB, and PF4 in the patient groups could be a simple dilution effect by the larger blood volumes obtained in these patients, compared with normal subjects. However, the observation that these substances were not reduced in thrombasthenics, in whom the blood volumes were similarly increased relative to normal subjects, argues against this possibility. A more likely explanation for the reductions seen at later time points in the various patient groups is an impairment of platelet thrombus formation at the ends of transected vessels, as has been previously shown in biopsy specimens of bleeding-time wounds in human^^,^ or pigsL3 with vWD. This impairment in vWD may result directly from the absence of vWF, which has been shown to mediate thrombus formation on ~u b e n d o t h e l i u m~~.~~ and incorporation of platelets into polymerizing fibrin" through its ability to bind both GPIb14 and GPIIb-IIIa.'4 For reasons discussed earlier, a similar reduction in platelet activation products would also be anticipated in BSS, in which impaired platelet thrombus formation on subendothelium has also been des~r i b e d .~~,~' ,~~ In MPD, impaired thrombus formation could result from the deficiency of dense-granule ADP, which has been shown to modulate thrombus formation on s~bendothelium~~ and on transected vessel^.^^^^^ Thus, the reduced TxBJPF4 values in the late bleedingtime samples of the patient groups are consistent with previously described abnormalities of platelet function in these disorders and provide further support for the importance of platelet-granule substances, and the interaction of vWF with its platelet receptors, in activating platelets and promoting hemostatically effective platelet plugs in normal hemostasis.
FPA
In contrast to the platelet activation substances, FPA levels in the early bleeding-time samples, as shown by the calculated initial slopes, were not decreased versus controls in any of the disorders studied, including ITP, and were increased in TSA, strongly suggesting that platelets are not required for fibrin formation during the early stages of hemostasis. In biopsy specimens of bleeding-time wounds obtained 1 to 2 minutes after incision, fibrin was found initially along the sides of the wound, and subsequently at the periphery of the platelet plugs that protrude from the ends of transected vessels.'~'' In previous studies we have shown that platelets play a role in fibrin deposition on subendothelium at high shear rates (>650 s-' in the model tested), but are not required at lower shear rate^,^' as might be found in some areas of the bleeding-time wounds. Thus, the normal or increased FPA values found in all of the patients groups in early bleeding-time specimens are consistent with these previous observations, and suggest that initial fibrin formation occurs independently of platelets in the low-shear environment of the wound edges.
However, the FPA values at 5 minutes and beyond were modestly decreased in all the patient groups except TSA. This corresponds to a relatively late stage in the arrest of bleeding in normal subjects, at which time the fibrin cap at the periphery of the hemostatic plug becomes greatly enlarged.'.'' Thus, in contrast to the initial fibrin formation that appears to occur independently of platelets under lowshear conditions in the wound, platelets may be required for later fibrin formation in the higher shear environment at the periphery of the hemostatic plugs. These plugs could provide the primary surface on which both thrombin generation and fibrin formation are l~calized,~' thereby consolidating the processes responsible for the final arrest of bleeding.
The greatest reduction in FPA levels, and hence presumably in thrombin generation in later bleeding-time samples, was found in vWD. In previous studies of FPA formation in bleeding-time blood from patients with coagulation deFor personal use only. on November 16, 2017 . by guest www.bloodjournal.org From fectsI6 we found that thrombin generation was normal in hemophilic patients and appeared to occur primarily via a tissue factor/Factor VII-mediated pathway. Thus, while the marked reduction of FTA in vWD is not likely to be caused by the concomitant factor VI11 deficiency, it might be explained by earlier findings that patients with vWD may have an abnormality in the expression of tissue
TSA
The increased values for both the platelet activation indicators TxB, and PF4 and the coagulation indicator FPA obtained in the early bleeding-time samples in TSA, which was in marked contrast to the results obtained in all other platelet disorders, require special attention, particularly in view of the current interest in preventing thrombosis and reocclusion of thrombosed vessels with agents that can block the receptor properties of GPIIb-IIIa.59 The increased FPA production is consistent with increased fibrin formation and FPA production on subendothelium observed in ex vivo studies using thrombasthenic blood.3' Because it is highly unlikely that platelet thrombus formation occurs to any significant extent in thrombasthenic patients (although masses of platelets entrapped within fibrin have been described in bleeding time wounds'), the TxB, and PF4 in early bleeding-time samples from these patients most likely originate from platelets adherent to collagen (or other adhesive substrates) and/or from thrombin-induced activation of circulating platelets within the wound. In vitro dose-response studies (Fig 3A) showed that greater than normal amounts of TxB2 were produced at equivalent thrombin concentrations by thrombasthenic platelets, which lack the GPIIb-IIIa receptor complex, but not by normal platelets in which the receptor was blocked by a complex-specific MoAb (Fig 3B) . It is not clear whether the increased platelet activation evident in early bleeding-time samples is related to the actual absence ofthe GPIIb-IIIa complex on the platelet surface (rather than just the loss of receptor function), to the acquisition of an enhanced Tx production in circulating thrombasthenic platelets, or to an increased production of thrombin, as may be reflected by the increased FPA values. In addition, these possibilities may not be independent of each other. However, whatever mechanisms are involved in TSA, it is entirely possible that increased activation of platelets and coagulation might also occur in vivo in normal subjects receiving agents that block the GPIIb-IIIa receptor, and this effect could counteract their intended antithrombotic properties.
Finally, as indicated earlier, although the curves that were fitted to the data in the present study enabled the calculation of several parameters of interest, they were entirely empirical and do not necessarily imply any particular model of hemostasis. Thus, it may be appropriate to develop models for the production of platelet-fibrin plugs that will predict the pattern of bleeding and the appearance of platelet and coagulation activation products in blood from bleeding time, and other types of wounds, and which may be tested experimentally by measurements similar to those used in the present study. 
